Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Deighton

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nature Reviews. Rheumatology|October 30, 2009
Therapy: what should we do after the failure of a first anti-TNF?Chris Deighton
Musculoskeletal Care|October 17, 2006
The updated BSR guidelines for anti-TNF in adults with RA: what has changed and why?Chris Deighton
Rheumatology (Oxford, England)|August 6, 2010
If it works why can't we have it? Sequential anti-TNF therapy in the UKChris Deighton
Current Drug Safety|August 12, 2008
Adverse dermatological reactions in rheumatoid arthritis patients treated with etanercept, an anti-TNFalpha drugShyra Rajakulendran, Chris Deighton
Nature Clinical Practice. Rheumatology|July 31, 2008
International guidelines on access to biologic therapy: why the differences and which is best?Chris Deighton, Kimme Hyrich
Musculoskeletal Care|October 17, 2006
The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelinesChris Deighton, Kate Gadsby
Clinical Medicine (London, England)|May 5, 2010
How does rheumatoid arthritis need to be managed?Chris Deighton, Michael Rudolf
BMJ (Clinical Research Ed.)|January 4, 2011
Treating inflammatory arthritis earlyChris Deighton, David L Scott
Current Rheumatology Reports|September 16, 2006
Recent advances in the genetics of rheumatoid arthritisChris Deighton, Lindsey A Criswell
Clinical Medicine (London, England)|March 17, 2011
A survey of new to follow-up ratios in rheumatology outpatient departmentsMarwan Bukhari, Josh Dixey, Chris Deighton
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nature Reviews. Rheumatology|October 30, 2009
Therapy: what should we do after the failure of a first anti-TNF?Chris Deighton
Musculoskeletal Care|October 17, 2006
The updated BSR guidelines for anti-TNF in adults with RA: what has changed and why?Chris Deighton
Rheumatology (Oxford, England)|August 6, 2010
If it works why can't we have it? Sequential anti-TNF therapy in the UKChris Deighton
Current Drug Safety|August 12, 2008
Adverse dermatological reactions in rheumatoid arthritis patients treated with etanercept, an anti-TNFalpha drugShyra Rajakulendran, Chris Deighton
Nature Clinical Practice. Rheumatology|July 31, 2008
International guidelines on access to biologic therapy: why the differences and which is best?Chris Deighton, Kimme Hyrich
Musculoskeletal Care|October 17, 2006
The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelinesChris Deighton, Kate Gadsby
Clinical Medicine (London, England)|May 5, 2010
How does rheumatoid arthritis need to be managed?Chris Deighton, Michael Rudolf
BMJ (Clinical Research Ed.)|January 4, 2011
Treating inflammatory arthritis earlyChris Deighton, David L Scott
Current Rheumatology Reports|September 16, 2006
Recent advances in the genetics of rheumatoid arthritisChris Deighton, Lindsey A Criswell
Clinical Medicine (London, England)|March 17, 2011
A survey of new to follow-up ratios in rheumatology outpatient departmentsMarwan Bukhari, Josh Dixey, Chris Deighton
Pageof 3